In celebration of Irene

Today Nystagmus Network’s Sue and Sara are travelling to Leicester University to attend a day of celebrations. We shall be marking 20 years of ophthalmology in Leicester and, in particular, the work of Professor Irene Gottlob.

The programme for the day, at the Ulverscroft Eye Unit, includes a range of presentations on various eye conditions, including, of course, nystagmus.

Dr Helena Lee, University Hospital Southampton, will speak on her trials using oral Levodopa to rescue retinal morphology and visual function in a murine model of human albinism.

Dr Mervin Thomas, University of Leicester, will present on the development and clinical utility of a diagnostic nystagmus gene panel using targeted next-generation sequencing.

Sohaib Rufai, Clinical Fellow at University of Leicester, will explore whether handheld OCT can predict future vision in infantile nystagmus.

Leah Haywood, University of Leicester, will discuss facial recognition in infantile nystagmus.

Dr Frank Proudlock, University of Leicester, will talk on reading in infantile nystagmus.

Nystagmus Network research conference 2019.

Nystagmus research conference 2019

The Nystagmus Network will once again be hosting a UK nystagmus research conference in 2019.

Following the success of last year’s event, attended by research and clinical teams from the Universities of Cardiff, Sheffield, Plymouth and Southampton and from Moorfields Eye Hospital and Fight for Sight, the charity will be funding a further event with a view to bringing about ever closer collaboration between teams and seeking out new and collaborative ways to make rare resources stretch even further.

As testing and detection become ever more sophisticated, it is hoped that outcomes for babies born with nystagmus will continue to improve, with effective treatments, prevention and even cure moving closer. In addition, therapies and interventions for young people and adults with congenital and acquired nystagmus continue to be explored.

This year’s conference takes place at the University of Cardiff in September. Delegates from across the UK have been invited and the charity is delighted to announce that representation from Leicester, London, Plymouth, Southampton and, of course, Cardiff is already confirmed. Clinicians, researchers and academics will be joined by Research Manager at Fight for Sight, Neil Meemaduma and those Nystagmus Network trustees who sit on the charity’s research committee.

Research teams will also attend the Nystagmus Network Open Day in Cardiff on Saturday 28 September, where they will be available to speak with delegates about their work.

Researcher presenting at Open Day.

More rejections than Harry Potter?

 

A report by John Sanders who, at different times, has been a Nystagmus Network trustee, as well as an employee and continues to be a member of the charity.

The other day I went to a talk entitled “My wobbles through the world of nystagmus” by Southampton based ophthalmologist, Helena Lee. This was part of Cardiff University’s School of Optometry and Vision Sciences’ “Cornea to Cortex” series of lectures.

Helena’s key message was: “We are making progress in understanding nystagmus, but it’s not easy.” For instance, Helena has done ground-breaking research into the use of OCT (Optical Coherence Tomography) scans as a diagnostic tool for nystagmus. Her research has been published and its findings are now pretty much accepted, but only after numerous rejections.

It’s largely thanks to Helena’s persistence (supported by colleagues in Leicester and Southampton) that OCT is now available for some children with early onset nystagmus (aka congenital nystagmus). Six years ago no-one even knew whether or not you could use an OCT scanner on an infant with moving eyes.

Some of the obstacles to answering that question were pretty basic. It was only through trial and error that Helena learned how to get one year olds to sit still long enough to scan their eyes. Making sure they’re fed and having the right cuddly toys to hand helps greatly.

Next, when you have the scans, how do you know what a normal infant retina looks like? And how might it differ in a child with nystagmus, achromatopsia or albinism? No-one knew the answer to those questions either. So Helena and her colleagues had to create a database of OCT scans from hundreds of children. Some had conditions like nystagmus, while others had no eye conditions.

Visible benefits
Thanks to that project, OCT scans are now providing benefits for families affected by nystagmus. The scans help provide a faster, more accurate diagnosis of nystagmus and its possible underlying causes. If you know the likely underlying cause, it often means you can give the family a better idea of how a child’s vision will be affected by nystagmus when they grow up.

In the longer term, early diagnosis may even lead to early intervention and treatment, which could in turn mean better vision. Note to adults (including me): the emphasis is on the word early. Helena’s work suggests there may be a window of opportunity in infancy to intervene before the eyes fully develop. Miss that opportunity and it’s much less clear whether treatment may be possible in adults.

As for the nature of treatment, at the moment it looks possible that it may be gene based. That’s one of the areas where Helena expects to see progress in the coming years. For now, though, the reality is that even OCT as a diagnostic tool for nystagmus in children is available in only a handful of UK hospitals. On top of that, getting research funded is not easy.

Lots more questions
Helena applied for and was turned down 11 times for funding for a project to look at a possible treatment to improve vision in infants with albinism. She reckons that’s more rejections than J K Rowling had with the first “Harry Potter” book. Finally, Helena struck lucky with an MRC (Medical Research Council) grant, but admits she was tempted more than once to give up her dream of pursuing research.

And we do need more research, because there are so many unanswered questions about nystagmus. For instance, does nystagmus cause the abnormalities in the eye picked up by OCT scans? Or do those abnormalities cause nystagmus? Initial signs are that the answer is likely to be complex and involve both the eye and the vision system in the brain.

One final thought that some may find surprising. Even if early intervention and treatment does become possible, current evidence suggests that simply stopping nystagmus in infancy won’t necessarily lead to normal vision. Hopefully it will lead to better vision than no intervention at all, but at the moment we can’t even be sure of that.

John Sanders
March 2018